X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (570) 570
child (367) 367
rhabdomyosarcoma (361) 361
female (360) 360
male (350) 350
index medicus (306) 306
child, preschool (291) 291
oncology (283) 283
adolescent (281) 281
infant (217) 217
pediatrics (212) 212
rhabdomyosarcoma - mortality (207) 207
children (180) 180
prognosis (180) 180
rhabdomyosarcoma - pathology (175) 175
adult (174) 174
cancer (155) 155
intergroup rhabdomyosarcoma (154) 154
rhabdomyosarcoma - therapy (148) 148
sarcoma (146) 146
chemotherapy (142) 142
surgery (135) 135
retrospective studies (128) 128
tumors (121) 121
survival rate (118) 118
combined modality therapy (106) 106
treatment outcome (98) 98
alveolar rhabdomyosarcoma (91) 91
disease-free survival (87) 87
radiotherapy (85) 85
hematology (84) 84
neoplasm staging (83) 83
childhood (76) 76
infant, newborn (76) 76
antineoplastic combined chemotherapy protocols - therapeutic use (74) 74
diagnosis (70) 70
rhabdomyosarcoma - surgery (70) 70
care and treatment (68) 68
soft-tissue sarcoma (68) 68
middle aged (67) 67
rhabdomyosarcoma - drug therapy (66) 66
young adult (66) 66
embryonal rhabdomyosarcoma (65) 65
rhabdomyosarcoma - diagnosis (65) 65
survival analysis (64) 64
follow-up studies (63) 63
metastasis (63) 63
survival (59) 59
analysis (57) 57
pathology (56) 56
rhabdomyosarcoma, alveolar - pathology (53) 53
age factors (51) 51
aged (50) 50
research (50) 50
rhabdomyosarcoma - genetics (50) 50
sarcoma - pathology (50) 50
animals (49) 49
childhood rhabdomyosarcoma (49) 49
childrens oncology group (48) 48
patients (48) 48
immunohistochemistry (47) 47
prognostic-factors (47) 47
medical prognosis (46) 46
radiology, nuclear medicine & medical imaging (46) 46
expression (45) 45
rhabdomyosarcoma, alveolar - mortality (45) 45
sarcoma - mortality (45) 45
health aspects (43) 43
therapy (43) 43
soft tissue neoplasms - pathology (42) 42
adolescents (41) 41
rhabdomyosarcoma - radiotherapy (41) 41
rhabdomyosarcoma, embryonal - mortality (41) 41
risk factors (41) 41
pediatric (40) 40
neoplasm metastasis (39) 39
soft-tissue sarcomas (39) 39
article (38) 38
sarcoma - therapy (38) 38
medicine & public health (37) 37
head and neck neoplasms - mortality (36) 36
hematology, oncology and palliative medicine (36) 36
kaplan-meier estimate (36) 36
radiation therapy (36) 36
experience (35) 35
soft tissue neoplasms - mortality (35) 35
head (34) 34
diagnosis, differential (33) 33
soft tissue sarcoma (33) 33
neuroblastoma (32) 32
otorhinolaryngology (32) 32
time factors (32) 32
gene expression (31) 31
neoplasm recurrence, local (31) 31
adolescence (30) 30
mice (30) 30
multivariate analysis (30) 30
rhabdomyosarcoma, embryonal - pathology (30) 30
age (29) 29
management (29) 29
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2010, Volume 28, Issue 13, pp. 2151 - 2158
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2013, Volume 49, Issue 16, pp. 3462 - 3470
Abstract Background Rhabdomyosarcoma (RMS) is an aggressive soft tissue tumour mainly affecting children and adolescents. Since survival of high-risk patients... 
Hematology, Oncology and Palliative Medicine | Anaplastic lymphoma kinase receptor | Insulin-like growth factor 1 receptor | Embryonal rhabdomyosarcoma | Targeted treatment | In vitro | Alveolar rhabdomyosarcoma | METASTATIC RHABDOMYOSARCOMA | MONOCLONAL-ANTIBODY | MECHANISMS | COMBINATION | ONCOLOGY | RESISTANCE | INTERGROUP | OUTCOMES | INHIBITOR | IGF-1 RECEPTOR | EXPRESSION | Receptor, IGF Type 1 - metabolism | Receptor, IGF Type 1 - antagonists & inhibitors | Humans | Middle Aged | Child, Preschool | Infant | Molecular Targeted Therapy | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Dose-Response Relationship, Drug | Young Adult | Netherlands | Rhabdomyosarcoma, Alveolar - mortality | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Rhabdomyosarcoma, Alveolar - pathology | Child | Infant, Newborn | Rhabdomyosarcoma, Embryonal - pathology | Rhabdomyosarcoma, Alveolar - drug therapy | Cell Survival - drug effects | Rhabdomyosarcoma, Embryonal - enzymology | Kaplan-Meier Estimate | Rhabdomyosarcoma, Embryonal - mortality | Rhabdomyosarcoma, Embryonal - drug therapy | Chi-Square Distribution | Receptor Protein-Tyrosine Kinases - metabolism | Drug Synergism | Rhabdomyosarcoma, Alveolar - enzymology | Adolescent | Cell Line, Tumor | Aged | Protein Kinase Inhibitors - pharmacology | Lymphomas
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 11/2015, Volume 21, Issue 21, pp. 4868 - 4880
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 2, pp. 635 - 642
Purpose To report the clinical outcome and late side effect profile of proton radiotherapy in the treatment of children with parameningeal rhabdomyosarcoma... 
Radiology | Hematology, Oncology and Palliative Medicine | Conformal radiotherapy | Late effects | Proton radiotherapy | Parameningeal rhabdomyosarcoma | Pediatric | NECK RHABDOMYOSARCOMA | HEAD | INTERGROUP RHABDOMYOSARCOMA | INTERNATIONAL-SOCIETY | INTENSITY-MODULATED RADIOTHERAPY | NONMETASTATIC RHABDOMYOSARCOMA | SOFT-TISSUE | CHILDREN | CHILDHOOD-CANCER | ONCOLOGY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PEDIATRIC-ONCOLOGY | Follow-Up Studies | Protons - adverse effects | Humans | Child, Preschool | Protons - therapeutic use | Infant | Male | Radiotherapy - adverse effects | Organ Sparing Treatments - methods | Rhabdomyosarcoma - radiotherapy | Meningeal Neoplasms - drug therapy | Rhabdomyosarcoma, Alveolar - mortality | Massachusetts | Female | Rhabdomyosarcoma - drug therapy | Child | Rhabdomyosarcoma - mortality | Rhabdomyosarcoma, Alveolar - drug therapy | Rhabdomyosarcoma, Alveolar - radiotherapy | Treatment Outcome | Rhabdomyosarcoma, Embryonal - mortality | Rhabdomyosarcoma, Embryonal - drug therapy | Meningeal Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Meningeal Neoplasms - radiotherapy | Rhabdomyosarcoma, Embryonal - radiotherapy | Radiotherapy | Medical colleges | Nuclear radiation | DIAGNOSIS | PATIENTS | NEOPLASMS | FAILURES | PHOTONS | TEETH | RADIATION DOSES | CARIES | HISTOLOGY | PROTONS | SINUSES | MEDICAL RECORDS | NOSE | RADIATION DOSE UNITS | RADIOLOGY AND NUCLEAR MEDICINE | PEDIATRICS | RADIOTHERAPY | SIDE EFFECTS | COBALT | CONTROL
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 93, Issue 5, pp. 1071 - 1076
Journal Article
Modern Pathology, ISSN 0893-3952, 06/2013, Volume 26, Issue 6, pp. 772 - 781
Rhabdomyosarcoma is a rare soft tissue sarcoma that typically affects children, adolescents, and young adults. Despite treatment via a multidisciplinary... 
Immunohistochemistry | Anaplastic lymphoma kinase | Fluorescence in situ hybridization | Rhabdomyosarcoma | ALK | PROTEIN | anaplastic lymphoma kinase | FUSION GENE | PATHOLOGY | IDENTIFICATION | CHILDRENS ONCOLOGY GROUP | fluorescence in situ hybridization | CELL LUNG-CANCER | INFLAMMATORY MYOFIBROBLASTIC TUMOR | ALVEOLAR RHABDOMYOSARCOMA | ONCOGENIC MUTATIONS | immunohistochemistry | rhabdomyosarcoma | EXPRESSION | Prognosis | Humans | Middle Aged | Child, Preschool | Male | Rhabdomyosarcoma, Embryonal - genetics | Young Adult | Rhabdomyosarcoma, Alveolar - therapy | DNA Mutational Analysis | Rhabdomyosarcoma, Alveolar - mortality | Rhabdomyosarcoma, Embryonal - therapy | Polymerase Chain Reaction | Adult | Female | Receptor Protein-Tyrosine Kinases - analysis | Rhabdomyosarcoma, Alveolar - pathology | Child | Rhabdomyosarcoma, Embryonal - pathology | Rhabdomyosarcoma, Alveolar - genetics | Rhabdomyosarcoma, Embryonal - enzymology | Biomarkers, Tumor - analysis | Kaplan-Meier Estimate | In Situ Hybridization, Fluorescence | Gene Dosage | Rhabdomyosarcoma, Embryonal - mortality | Forkhead Transcription Factors - genetics | Gene Amplification | Receptor Protein-Tyrosine Kinases - genetics | Rhabdomyosarcoma, Alveolar - enzymology | Gene Rearrangement | Adolescent | Biomarkers, Tumor - genetics | Forkhead Box Protein O1 | Mutation
Journal Article
International Journal of Radiation Oncology Biology Physics, ISSN 0360-3016, 04/2012, Volume 82, Issue 5, pp. 1764 - 1770
Purpose: To compare the dosimetric parameters of intensity-modulated radiotherapy (IMRT) and three-dimensional conformal radiotherapy (3D-CRT) in patients with... 
Intensity-modulated radiotherapy | 3D-CRT | IMRT | Three-dimensional conformal radiotherapy | Rhabdomyosarcoma | Intermediate risk | TISSUE | CANCER | RADIATION-THERAPY | TRIAL | ONCOLOGY | NECK-RHABDOMYOSARCOMA | CARCINOMA | SURVIVORS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Organs at Risk - radiation effects | Humans | Rhabdomyosarcoma - pathology | Male | Radiotherapy, Intensity-Modulated - adverse effects | Rhabdomyosarcoma - radiotherapy | Rhabdomyosarcoma, Alveolar - mortality | Treatment Failure | Sarcoma - mortality | Female | Rhabdomyosarcoma - drug therapy | Rhabdomyosarcoma, Alveolar - pathology | Child | Rhabdomyosarcoma - mortality | Sarcoma - radiotherapy | Rhabdomyosarcoma, Embryonal - pathology | Radiotherapy, Intensity-Modulated - mortality | Rhabdomyosarcoma, Alveolar - drug therapy | Radiotherapy, Intensity-Modulated - methods | Rhabdomyosarcoma, Alveolar - radiotherapy | Rhabdomyosarcoma, Embryonal - mortality | Rhabdomyosarcoma, Embryonal - drug therapy | Sarcoma - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Epidemiologic Methods | Radiotherapy, Conformal - mortality | Radiotherapy, Conformal - adverse effects | Rhabdomyosarcoma, Embryonal - radiotherapy | Radiotherapy, Conformal - methods | Nuclear radiation | Analysis | Radiation | Medical care | Universities and colleges | Radiotherapy | Methods | Quality management | Index Medicus | PATIENTS | NEOPLASMS | INTEGRAL DOSES | FAILURES | TOXICITY | COMPARATIVE EVALUATIONS | CHILDREN | PLANNING | MULTIVARIATE ANALYSIS | RADIOLOGY AND NUCLEAR MEDICINE | REGRESSION ANALYSIS | RADIOTHERAPY | CONTROL | HAZARDS
Journal Article